WHO grade II meningioma: Epidemiology, survival and contribution of postoperative radiotherapy in a multicenter cohort of 88 patients
Authors:
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Neurochirurgie
- Vol. 66 (2) , 73-79
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Molecular genetics of meningiomas: Building the roadmap towards personalized therapyNeurochirurgie, 2018
- An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomasNeurosurgical Focus, 2015
- Radiotherapy versus Observation following surgical resection of Atypical Meningioma (the ROAM trial)Neuro-Oncology, 2014
- Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatmentActa Neurochirurgica, 2014
- Atypical meningiomas: is postoperative radiotherapy indicated?Neurosurgical Focus, 2013
- Intracranial meningiomas of atypical (WHO grade II) histologyJournal of Neuro-Oncology, 2010
- WHO grade II and III meningiomas: a study of prognostic factorsJournal of Neuro-Oncology, 2009
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- The accuracy of meningioma grading: a 10‐year retrospective auditNeuropathology and Applied Neurobiology, 2005
- THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENTJournal of Neurology, Neurosurgery & Psychiatry, 1957